Evidence map›Paper›PMID 38108355›Full record

ArticleJournal of Huntington's disease2023

An Overview of Specialist Services for Huntington's Disease in the United Kingdom.

Rosa Willock, Hugh Rickards, Anne E Rosser, Alistair Haw, Cath Stanley, Pushpa Hossain, Idaira Rodríguez-Santana, Maria Doherty, Rachel Blair, Wendy Kane

Abstract read
In one paragraph

Article in Journal of Huntington's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rosa WillockHCD Economics, Cheshire, England, UK.
Hugh RickardsBirmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, England, UK.
Anne E RosserSchools of Medicine and Biosciences, Cardiff University, Cardiff, Wales, UK.
Alistair HawScottish Huntington's Association, Paisley, Scotland, UK.
Cath StanleyHuntington's Disease Association, Liverpool, England, UK.
Pushpa HossainHCD Economics, Cheshire, England, UK.
Idaira Rodríguez-SantanaHCD Economics, Cheshire, England, UK.
Maria DohertyHCD Economics, Cheshire, England, UK.
Rachel BlairRoche Products Ltd., Welwyn Garden City, England, UK.
Wendy KaneRoche Products Ltd., Welwyn Garden City, England, UK.

Funding

HCRW_ RFPPB-16A-1298Medical Research Council MR/L010305/1
6 · The paper itself

Abstract

backgroundHuntington's disease (HD) is a rare inherited neurodegenerative disorder characterized by complex evolving needs that change as the condition progresses. There is limited understanding about the organization of HD clinical services and their resourcing in the United Kingdom (UK).

objectiveTo understand the organization and resourcing of specialist HD services for people with HD (PwHD) in the UKMethods:This cross-sectional study collected quantitative data via on online survey, and qualitative data via telephone semi-structured interviews. Descriptive statistics were used to describe quantitative outcomes, and qualitative results were analyzed using content analysis.

resultsA total of 31 specialist services for HD were identified. Of the 27 services that completed the online survey, 23 had an active multidisciplinary team of healthcare professionals (HCPs) and were led primarily by a mental health trust (26%) or tertiary referral hospital (26%). Specialist services offered outpatient clinics (96%), outreach in the community (74%), telemedicine (70%), inpatient beds (26%) and satellite clinics (26%). Many services indicated that their capacity (ability to see patients as often as needed with current resources) was difficult, with some services reporting more difficulty at the early or later stages of HD. Key resourcing gaps were identified with access to facilities, HCPs and referral networks.

conclusionsThis research highlights the variation in organization and capacity within individual HD services as well as current resourcing and gaps in access that influence this capacity. Further research should be done to understand the impact of service organization and current resourcing gaps in access on the quality of care provided for PwHD in the UK.

Indexed as

Huntington DiseaseTelemedicineAmbulatory Care FacilitiesCross-Sectional StudiesHumansUnited Kingdomhealth services capacityhealth services organizationHuntington’s diseaseNHSUnited Kingdom

Identifiers

PMID38108355
PMCPMC10741324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.